Skip to main content
SpringerLink
Log in

Neurosarkoidose bleibt ein diagnostisches Chamäleon

Erstmanifestation einer Neurosarkoidose als longitudinale Myelitis transversa

Neurosarcoidosis remains a diagnostic chameleon

First manifestation of neurosarcoidosis as longitudinal transverse myelitis

  • Kurzbeiträge
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Ungprasert P, Carmona EM, Utz JP et al (2016) Epidemiology of Sarcoidosis 1946–2013: a population-based study. Mayo Clin Proc 91:183

    Article  Google Scholar 

  2. Kreuter et al (2016) Seltene Lungenerkrankungen. Springer, Berlin, Heidelberg. ISBN 978-3662484197

    Book  Google Scholar 

  3. Thomas (2016) Histopathologie: Lehrbuch und Atlas zur Befunderhebung und Differenzialdiagnostik, 14. Aufl. Schattauer, Stuttgart. ISBN 978-3794524297

    Google Scholar 

  4. Burns TM (2003) Neurosarcoidosis. Arch Neurol 60:1166

    Article  Google Scholar 

  5. Joseph FG, Scolding NJ (2007) Sarcoidosis of the nervous system. Pract Neurol 7:234

    Article  CAS  Google Scholar 

  6. Stern BJ, Krumholz A, Johns C et al (1985) Sarcoidosis and its neurological manifestations. Arch Neurol 42:909

    Article  CAS  Google Scholar 

  7. Reith W, Roumia S, Popp C (2016) Radiologe 56:898. https://doi.org/10.1007/s00117-016-0168-9

    Article  CAS  PubMed  Google Scholar 

  8. Klinker F (2017) Visuell Evozierte Potentiale – Technik und klinische AnwendungVisual evoked potentials – methodology and clinical application. Neurophysiol Labor 39(2):69–80

    Article  Google Scholar 

  9. Stern BJ, Corbett J (2007) Neuro-ophthalmologic manifestations of Sarcoidosis. Curr Treat Options Neurol 9:63

    Article  Google Scholar 

  10. Moravan M, Segal BM (2009) Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil. Neurology 72:337

    Article  CAS  Google Scholar 

  11. Santos E, Shaunak S, Renowden S, Scolding NJ (2010) Treatment of refractory neurosarcoidosis with Infliximab. J Neurol Neurosurg Psychiatry 81:241

    Article  Google Scholar 

  12. Gelfand JM, Bradshaw MJ, Stern BJ, Clifford DB, Wang Y, Cho TA, Koth LL, Hauser SL, Dierkhising J, Vu N, Sriram S, Moses H, Bagnato F, Kaufmann JA, Ammah DJ, Yohannes TH, Hamblin MJ, Venna N, Green AJ, Pawate S (2017) Infliximab for the treatment of CNS sarcoidosis: a multi-institutional series. Neurology 89(20):2092–2100. https://doi.org/10.1212/WNL.0000000000004644

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Cohen Aubart F, Bouvry D, Galanaud D, Dehais C, Mathey G, Psimaras D, Haroche J, Pottier C, Hie M, Mathian A, Devilliers H, Nunes H, Valeyre D, Amoura Z (2017) Long-term outcomes of refractory neurosarcoidosis treated with infliximab. J Neurol 264(5):891–897. https://doi.org/10.1007/s00415-017-8444-9

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Innere Medizin, Spital Linth, Gasterstraße 25, 8730, Uznach, Schweiz

    Anna Heinen & David Czell

  2. Klinik für Neurologie, UniversitätsSpital Zürich, Zürich, Schweiz

    Sven Schippling

Authors
  1. Anna Heinen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sven Schippling
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David Czell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anna Heinen.

Ethics declarations

Interessenkonflikt

A. Heinen, S. Schippling und D. Czell geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Heinen, A., Schippling, S. & Czell, D. Neurosarkoidose bleibt ein diagnostisches Chamäleon. Nervenarzt 90, 412–414 (2019). https://doi.org/10.1007/s00115-018-0652-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-018-0652-8

Search

Navigation